Mechanisms Regulating Muscle Protein Synthesis in CKD

Abstract
Background CKD induces loss of muscle proteins partly by suppressing muscle protein synthesis. Muscles of mice with CKD have increased expression of nucleolar protein 66 (NO66), as do muscle biopsy specimens from patients with CKD or those undergoing hemodialysis. Inflammation stimulates NO66 expression and changes in NF-kappa B mediate the response. Methods Subtotal nephrectomy created a mouse model of CKD with BUN >80mg/dl. Crossing NO66(flox/flox) with MCK-Cre mice bred muscle-specific NO66 (MCK-NO66) knockout mice. Experiments assessed the effect of removing NO66. Results Muscle-specific NO66 knockout in mice blocks CKD-induced loss of muscle mass and improves protein synthesis. NO66 suppression of ribosomal biogenesis via demethylase activity is the mechanism behind these responses. In muscle cells, expression of NO66, but not of demethylase-dead mutant NO66, decreased H3K4me3 and H3K36me3 and suppressed pre-rRNA expression. Knocking out NO66 increased the enrichment of H3K4me3 and H3K36me3 on ribosomal DNA. In primary muscle cells and in muscles of mice without NO66, ribosomal RNA, pre-rRNA, and protein synthesis all increased. Conclusions CKD suppresses muscle protein synthesis via epigenetic mechanisms that NO66 mediates. Blocking NO66 could suggest strategies that counter CKD-induced abnormal muscle protein catabolism.
Funding Information
  • National Institutes of Health (2R01 DK037175, P30-DK079638, R01-HL147108)
  • Center for Scientific Review
  • ADA Foundation (1-11-BS-194)
  • Norman S. Coplon
  • Dr. and Mrs. Harold Selzman
  • Abbott Nutrition
  • Fresenius Kabi